3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
7
Gastrointestinal
2
Thoracic
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Conditions
Leukemia, Myeloid, Acute
394
Precursor Cell Lymphoblastic Leukemia-Lymphoma
226
Hematologic Neoplasms
206
Leukemia, Lymphocytic, Chronic, B-Cell
175
Myelodysplastic Syndromes
144
Leukemia
125
Lymphoma
90
Lymphoma, Non-Hodgkin
76
Multiple Myeloma
67
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
67
Recurrence
55
Neoplasms
53
Leukemia, Myelomonocytic, Chronic
50
Burkitt Lymphoma
44
Lymphoma, Large B-Cell, Diffuse
41
Leukemia, Biphenotypic, Acute
41
Myeloproliferative Disorders
39
Lymphoma, Mantle-Cell
39
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
37
Hodgkin Disease
36
Lymphoma, B-Cell
32
Lymphoma, Follicular
31
Leukemia, B-Cell
27
Lymphoma, B-Cell, Marginal Zone
24
Anemia, Refractory, with Excess of Blasts
24
Waldenstrom Macroglobulinemia
23
Primary Myelofibrosis
21
Myelodysplastic-Myeloproliferative Diseases
20
Hematologic Diseases
19
Lymphoma, T-Cell
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Other hematologic neoplasm
×
90 days
×
Clear all
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled